JP2007538066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007538066A5 JP2007538066A5 JP2007517663A JP2007517663A JP2007538066A5 JP 2007538066 A5 JP2007538066 A5 JP 2007538066A5 JP 2007517663 A JP2007517663 A JP 2007517663A JP 2007517663 A JP2007517663 A JP 2007517663A JP 2007538066 A5 JP2007538066 A5 JP 2007538066A5
- Authority
- JP
- Japan
- Prior art keywords
- prevention
- dosage form
- treatment
- mucositis
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028116 Mucosal inflammation Diseases 0.000 claims 3
- 230000000259 anti-tumor Effects 0.000 claims 3
- 201000010927 mucositis Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 108010024093 sulglicotide Proteins 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 238000002512 chemotherapy Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 239000006201 parenteral dosage form Substances 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 239000006208 topical dosage form Substances 0.000 claims 1
Claims (8)
- 抗腫瘍治療による粘膜炎の治療および／または予防のための医薬組成物の製造のためにスルグリコチドを使用する方法。
- 口腔粘膜炎の治療および／または予防のための請求項１記載の使用方法。
- 該医薬組成物が抗腫瘍治療による粘膜炎の予防のためであることを特徴とする請求項１記載の使用方法。
- 抗腫瘍治療が化学療法および／または放射線療法である請求項１記載の使用方法。
- スルグリコチドが、12.5〜800mg/kgの量で投与される請求項１〜４のいずれか１項記載の使用方法。
- 該組成物が局所投与形態である請求項１〜５のいずれか１項記載の使用方法。
- 該医薬組成物が経口投与形態である請求項１〜６のいずれか１項記載の使用方法。
- 該組成物が非経口投与形態である請求項１〜７のいずれか１項記載の使用方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000989A ITMI20040989A1 (it) | 2004-05-18 | 2004-05-18 | Uso del sulglicotide per iul trattamento delle mucositi |
| ITMI2004A000989 | 2004-05-18 | ||
| PCT/IT2005/000272 WO2005110458A1 (en) | 2004-05-18 | 2005-05-12 | Use of sulglicotide for the treatement of mucositis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007538066A JP2007538066A (ja) | 2007-12-27 |
| JP2007538066A5 true JP2007538066A5 (ja) | 2008-06-26 |
| JP4874962B2 JP4874962B2 (ja) | 2012-02-15 |
Family
ID=34971240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007517663A Expired - Fee Related JP4874962B2 (ja) | 2004-05-18 | 2005-05-12 | 粘膜炎の治療のためのスルグリコチドの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7662777B2 (ja) |
| EP (1) | EP1747010B1 (ja) |
| JP (1) | JP4874962B2 (ja) |
| CN (1) | CN1972705B (ja) |
| BR (1) | BRPI0511165A (ja) |
| CA (1) | CA2565084C (ja) |
| IL (1) | IL178907A0 (ja) |
| IT (1) | ITMI20040989A1 (ja) |
| WO (1) | WO2005110458A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101851285B (zh) * | 2009-04-03 | 2012-09-12 | 四川德博尔制药有限公司 | 硫酸糖肽的制备方法 |
| KR101819709B1 (ko) * | 2017-01-13 | 2018-01-17 | (주)아이엠디팜 | 설글리코타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 약학 조성물 |
| CN115845127B (zh) * | 2022-12-29 | 2023-11-24 | 海南众森生物科技有限公司 | 一种多糖止血修复生物胶液及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1215332B (it) * | 1987-01-12 | 1990-02-08 | Crinos Industria Farmaco | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
| JPH06506939A (ja) * | 1991-04-12 | 1994-08-04 | クリエイティブ バイオモレキュルズ インコーポレイテッド | 血小板由来の成長因子に依る消化管潰瘍の治療方法 |
| US5496828A (en) | 1994-08-22 | 1996-03-05 | Eli Lilly And Company | Methods of inhibiting ulcerative mucositis |
| WO2003024391A2 (en) * | 2001-08-16 | 2003-03-27 | Mucosal Therapeutics, Inc. | Treatment and prevention of mucositis in cancer patients |
| EP1509234B1 (en) | 2002-05-21 | 2008-12-17 | Abbott Laboratories | Treatment of mucositis |
-
2004
- 2004-05-18 IT IT000989A patent/ITMI20040989A1/it unknown
-
2005
- 2005-05-12 JP JP2007517663A patent/JP4874962B2/ja not_active Expired - Fee Related
- 2005-05-12 WO PCT/IT2005/000272 patent/WO2005110458A1/en active Application Filing
- 2005-05-12 CA CA2565084A patent/CA2565084C/en not_active Expired - Fee Related
- 2005-05-12 US US11/569,095 patent/US7662777B2/en not_active Expired - Fee Related
- 2005-05-12 BR BRPI0511165-0A patent/BRPI0511165A/pt not_active IP Right Cessation
- 2005-05-12 CN CN2005800159271A patent/CN1972705B/zh not_active Expired - Fee Related
- 2005-05-12 EP EP05742993.8A patent/EP1747010B1/en not_active Not-in-force
-
2006
- 2006-10-26 IL IL178907A patent/IL178907A0/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504723A5 (ja) | ||
| JP2014532704A5 (ja) | ||
| CA2633594C (en) | Means and methods for the treatment of tumorous diseases | |
| JP2009516719A5 (ja) | ||
| JP2013527232A5 (ja) | ||
| JP2008514577A5 (ja) | ||
| JP2008505857A5 (ja) | ||
| TW200738735A (en) | Oxygen linked pyrimidine derivatives | |
| JP2005511597A5 (ja) | ||
| JP2011515481A5 (ja) | ||
| JP2015507020A5 (ja) | ||
| JP2016530291A5 (ja) | ||
| WO2007131070A3 (en) | Compositions, dosage forms and methods of treating emesis | |
| JP2007119497A5 (ja) | ||
| JP2005530735A5 (ja) | ||
| WO2008075320A3 (en) | Antilipidemic pharmaceutical compositions and process for preparation thereof | |
| JP2006514116A5 (ja) | ||
| NZ596226A (en) | Antitumor combination including cabazitaxel and capecitabine | |
| JP2007538066A5 (ja) | ||
| JP2006514681A5 (ja) | ||
| JP2008539169A5 (ja) | ||
| RU2012108144A (ru) | Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами | |
| JP2018506533A5 (ja) | ||
| MX2009001433A (es) | Nucleosidos para suprimir o reducir el desarrollo de resistencia en terapia citostatica. | |
| RU2005134430A (ru) | Способ базисного лечения хронического вирусного гепатита c |